Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-06-11, Stock:NVO, The news for the past five days is as follows:
2021-06-04: NEWS1: FDA approves Novo Nordisk’s obesity drug Wegovy, which helped people cut weight 15%.NEWS2: UPDATE 2-U.S. FDA approves Novo Nordisk's semaglutide as obesity treatment.NEWS3: Wegovy™ (semaglutide 2.4 mg), the first and only once-weekly GLP-1 therapy for weight management, approved in the US.
2021-06-07: NEWS1: Novo Nordisk (NVO) Semaglutide Gets FDA Nod for Obesity.NEWS2: Novo Nordisk's Semaglutide Gets FDA Approval to Tackle Obesity.NEWS3: Novo Nordisk A/S – Share repurchase programme.NEWS4: UPDATE 1-Risk of patient overlap between Wegovy and Saxenda obesity drugs, Novo says.NEWS5: Risk of patient overlap between Wegovy and Saxenda obesity drugs, Novo says.
2021-06-08: nan
2021-06-09: nan
2021-06-10: nan

Answer: Decrease